好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | C116 - Transforming Alzheimer’s disease Care: Clinical Applications of Plasma Biomarkers and Anti-Amyloid Therapies

Monday 04/20/26
03:30 PM - 05:30 PM CDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jonathan Graff-Radford, MD, FAAN
Aging, Dementia, and Behavioral Neurology
Participants should be able to appraise major findings from recent clinical trials of anti-amyloid monoclonal antibody therapies in Alzheimer's disease; understand imaging and fluid biomarkers relevant for treatment eligibility and monitoring
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Advanced
Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic
Event Timeline
03:30 PM - 03:55 PM CDT Speaker Update on Alzheimer's biomarkers
03:55 PM - 04:20 PM CDT Speaker Alzheimer's biomarkers: Clinical Case Studies
Jonathan Graff-Radford, MD, FAAN
04:20 PM - 04:45 PM CDT Speaker Anti-amyloid therapy updates
Jonathan Graff-Radford, MD, FAAN
04:45 PM - 05:10 PM CDT Speaker Anti-amyloid therapy: Clinical Case Studies
05:10 PM - 05:30 PM CDT Speaker Q&A
Faculty Disclosures
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .